NVS

Novartis AG

D
NVS
USD
-2.34
(-2.1389%)
Market Closed
48,755.00
Volume
7.275
EPS
3.27
Div Yield
21.894
P/E
216,751,446,475.50
Market Cap
Today
0.2153%
1 Week
-1.236%
1 Month
-5.989%
6 Months
8.054%
12 Months
14.088%
Year To Date
6.010%
All Time
43.305%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
VRTX
VRTX
9.22
(1.869%)
USD
LLY
LLY
-2.235
(-0.2794%)
USD
PFE
PFE
0.105
(0.3839%)
USD
SNY
SNY
-1.11
(-2.1003%)
USD
GSK
GSK
0.76
(2.117%)
USD
MRK
MRK
0.46
(0.4567%)
USD
ABBV
ABBV
-0.78
(-0.3876%)
USD
JNJ
JNJ
-1.03
(-0.6528%)
USD

Title:
Novartis AG

Sector:
Healthcare
Industry:
Drug Manufacturers - General
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Do you need help or have a question?
Contact Us